×

3_SAGE2018_WG_recommendation_FINAL.pdf

Home / Discover /www.who.int/immunization/sage/meetings/2018/october/

  Parent Folder


3_SAGE2018_WG_recommendation_FINAL.pdf
PDF 4 years ago 2.09 MB
Copy Link   
2_HPV_vaccine_background_document.pdf
PDF 4 years ago 1.69 MB
Copy Link   
4_SR_EE_HPV.pdf
PDF 4 years ago 1.04 MB
Copy Link   
0_Executive_Summary_for_SAGE_Session_on_HPV_revised.pdf
PDF 4 years ago 174.55 kB
Copy Link   
5_C4P_Gavi_demo_costing_2017.pdf
PDF 4 years ago 692.71 kB
Copy Link   
9_Goujon_Immune_response_YF_vaccine_infants_immunized_measles_France_Vaccine_2017.pdf
PDF 4 years ago 223.70 kB
Copy Link   
6_HPVGAVIIntroCost_June2014.pdf
PDF 4 years ago 194.08 kB
Copy Link   
8_Clarke_Appendix_Safety_Immunogenicity_IPV_MR_YF_vaccines_The_Gambia_Lancet_Glob_Health_2016.pdf
PDF 4 years ago 366.23 kB
Copy Link   
7_Quentin_et_al_2012_HPV.pdf
PDF 4 years ago 573.12 kB
Copy Link   
7_Clarke_Safety_Immunogenicity_IPV_MR_YF_vaccines_The_Gambia_Lancet_Glob_Health_2016.pdf
PDF 4 years ago 727.23 kB
Copy Link   
8_Hutubessy_HPVcostingTNZ_BMC2012.pdf
PDF 4 years ago 500.62 kB
Copy Link   
6_Nascimiento_Silva_et_al_Interference_MMR_and_YF_(Brazil)_Vaccine_2011.pdf
PDF 4 years ago 419.20 kB
Copy Link   
9__HPV_vaccines_in_females_over_25_years.pdf
PDF 4 years ago 1.84 MB
Copy Link   
5_WHO_Global_Measles_Ad_Hoc_Advisory_Committee.pdf
PDF 4 years ago 114.75 kB
Copy Link   
10_Worldwide_burden_of_cancer_HPV_2017.pdf
PDF 4 years ago 460.90 kB
Copy Link   
3_Country_classification_Guidance_measles_session_yellow_book_doc.pdf
PDF 4 years ago 693.29 kB
Copy Link   
11_HPV_Market_Study_Public_Summary_Sep_15_2018.pdf
PDF 4 years ago 302.10 kB
Copy Link   
2_Co-administration_YF_MCV_vaccines_measles_session_yellow_book_doc.pdf
PDF 4 years ago 509.06 kB
Copy Link   
1_Executive_Summary_SAGE_Ebola.pdf
PDF 4 years ago 255.82 kB
Copy Link   
1_Feasibility_of_Measles_Rubella_Eradication_measles_session_yellow_book_doc.pdf
PDF 4 years ago 311.55 kB
Copy Link   

Join FilePursuit on FilePursuit Discord Server chat for discussions and more information.